Loading ChartRhythms
Preparing market rhythm analysis...
Preparing market rhythm analysis...
Full Rhythm Report
PODD • Stock • Health Care / Health Care Equipment
Current Price
$131.69
+0.69%
Provider quote snapshot • As of 2026-10-02T20:00:00.000Z
Back to stock pageCross-Horizon Read
PODD's evidence points supportive across the available windows.
Generated 2026-10-05T11:20:00.000Z • Evidence ccebedd1
Price Data
A quote snapshot is available, but historical price data is not connected yet.
ChartRhythms displays a price chart only when real historical time-series data is available. No estimated or synthetic chart is shown.
0–3 days
Supporting articles
0
Opposing articles
0
Neutral articles
0
Confidence basis
Supporting evidence
No supporting articles were found in this window.
Opposing evidence
No opposing articles were found in this window.
Catalysts
No specific catalysts were identified in this window.
Risks
No specific risk mentions were identified in this window.
Next proof points
• Additional dated, company-specific coverage in the 0–3 days window.
Strengthens if
• Supporting evidence (0) grows relative to opposing evidence (0) in this window.
• No evidence is available for this window is resolved.
Weakens if
• Opposing evidence (0) grows relative to supporting evidence (0) in this window.
Sources in this window (0)
No sources are available for this window yet.
4–21 days
Supporting articles
0
Opposing articles
0
Neutral articles
0
Confidence basis
Supporting evidence
No supporting articles were found in this window.
Opposing evidence
No opposing articles were found in this window.
Catalysts
No specific catalysts were identified in this window.
Risks
No specific risk mentions were identified in this window.
Next proof points
22–90 days
The 22–90 days evidence set currently reads slightly bullish.
Supporting articles
4
Opposing articles
3
Neutral articles
8
Confidence basis
Supporting evidence
• Insulet (NASDAQ:PODD): Growth at a Reasonable Valuation
• Insulet (PODD) Q2 2026 Earnings Call Transcript
• Insulet Corp (PODD) (Q2 2026) Earnings Call Highlights: Strong Revenue Growth Offset by Type 2 ...
• Insulet Corp (PODD) (Q2 2026) Earnings Call Highlights: Strong Revenue Growth Offset by Type 2 ...
Help improve this analysis
This feedback is saved locally for the MVP. Later, ChartRhythms can use this feedback to improve the strategy engine.
Important:
ChartRhythms provides source-based market summaries for research and informational purposes only. This is not financial advice and not a recommendation to buy, sell, or hold any security.
• Additional dated, company-specific coverage in the 4–21 days window.
Strengthens if
• Supporting evidence (0) grows relative to opposing evidence (0) in this window.
• No evidence is available for this window is resolved.
Weakens if
• Opposing evidence (0) grows relative to supporting evidence (0) in this window.
Sources in this window (0)
No sources are available for this window yet.
Opposing evidence
• PODD Shareholder Alert: Insulet Corporation Securities Class Action Lawsuit - Investors With Losses May Contact The Gross Law Firm
• PODD Shareholder Alert: August 31, 2026 Lead Plaintiff Deadline in Insulet Corporation Securities Class Action - Contact SueWallSt
• Truist Securities Downgrades Insulet Corporation (PODD) to Hold
Catalysts
• Insulet (PODD) Q2 2026 Earnings Call Transcript
• PODD's Q2 Earnings Top Estimates, FY'26 Sales View Cut, Stock Down
• Insulet (PODD) Stock Looks Undervalued As The Market Stays Cautious
• Insulet (PODD) Is Down 21.9% After Cutting 2026 Revenue Outlook On Weaker Type 2 Retention
• Insulet Corp (PODD) (Q2 2026) Earnings Call Highlights: Strong Revenue Growth Offset by Type 2 ...
Risks
• Insulet (NASDAQ:PODD): Growth at a Reasonable Valuation
• PODD's Q2 Earnings Top Estimates, FY'26 Sales View Cut, Stock Down
• PODD Shareholder Alert: Insulet Corporation Securities Class Action Lawsuit - Investors With Losses May Contact The Gross Law Firm
• Insulet (PODD) Stock Looks Undervalued As The Market Stays Cautious
• Pomerantz Law Firm Announces the Filing of a Class Action Against Insulet Corporation and Certain Officers - PODD
Next proof points
• Continued coverage in the 22–90 days window confirming the current read.
Strengthens if
• Supporting evidence (4) grows relative to opposing evidence (3) in this window.
Weakens if
• Opposing evidence (3) grows relative to supporting evidence (4) in this window.
Showing 8 of 15 sources
Insulet (NASDAQ:PODD): Growth at a Reasonable Valuation
ChartMill • 2026-08-27 • Bullish
Open via Finnhub →PODD's Q2 Earnings Top Estimates, FY'26 Sales View Cut, Stock Down
Yahoo • 2026-08-10 • Mixed
Open via Finnhub →PODD Shareholder Alert: Insulet Corporation Securities Class Action Lawsuit - Investors With Losses May Contact The Gross Law Firm
GlobeNewswire • 2026-08-07 • Bearish
View source →Insulet (PODD) Stock Looks Undervalued As The Market Stays Cautious
Yahoo Finance • 2026-08-07 • Mixed
View source →Insulet (PODD) Stock Looks Undervalued As The Market Stays Cautious
Yahoo • 2026-08-07 • Mixed
Open via Finnhub →Pomerantz Law Firm Announces the Filing of a Class Action Against Insulet Corporation and Certain Officers - PODD
PR Newswire • 2026-08-06 • Mixed
View source →PODD Shareholder Alert: August 31, 2026 Lead Plaintiff Deadline in Insulet Corporation Securities Class Action - Contact SueWallSt
PR Newswire • 2026-08-06 • Bearish
View source →